MOSCOW (Reuters) -India has given regulatory approval to Russia’s one-shot Sputnik Light COVID-19 vaccine after it authorized Russia’s main vaccine – the two-dose Sputnik V – last year, the Russian Direct Investment Fund said on Sunday.
Sputnik Light, the first component of the Sputnik V vaccine, can be used as a booster shot with other vaccines, RDIF said.
Head of the fund Kirill Dmitriev called Sputnik Light in a statement “the solution to increase efficacy and duration of other vaccines, including against Omicron variant”.
RDIF struck deals with seven Indian pharmaceutical companies to make a total of 1 billion Sputnik doses both for export and for use in India.
(Reporting by Andrew Osborn, writing by Maria Tsvetkova, editing by Alexander Smith and Catherine Evans)
